Benzinga | Nov 19, 2021 08:21AM EST

Credit Suisse Maintains Outperform on Teladoc Health, Lowers Price Target to $207

Credit Suisse analyst Jailendra Singh maintains Teladoc Health (NYSE:TDOC) with a Outperform and lowers the price target from $208 to $207.